azatoxin has been researched along with ellipticine in 1 studies
| Studies (azatoxin) | Trials (azatoxin) | Recent Studies (post-2010) (azatoxin) | Studies (ellipticine) | Trials (ellipticine) | Recent Studies (post-2010) (ellipticine) |
|---|---|---|---|---|---|
| 11 | 0 | 2 | 454 | 0 | 178 |
| Protein | Taxonomy | azatoxin (IC50) | ellipticine (IC50) |
|---|---|---|---|
| Cytochrome P450 1A1 | Homo sapiens (human) | 0.0193 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.2 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cline, SD; Macdonald, TL; Osheroff, N | 1 |
1 other study(ies) available for azatoxin and ellipticine
| Article | Year |
|---|---|
Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Cattle; DNA; Drosophila; Drug Design; Ellipticines; Enzyme Inhibitors; Etoposide; Humans; Indoles; Intercalating Agents; Kinetics; Molecular Structure; Recombinant Proteins; Saccharomyces cerevisiae; Thymus Gland; Topoisomerase II Inhibitors | 1997 |